Clinical Trial Update: A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) [Phase 4]

View source ↗

Summary

Phase 4 safety study evaluating 6 months of ciclesonide nasal aerosol (Zetonna) and ciclesonide nasal spray (Omnaris) in subjects aged 12 years and older with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Omnaris (Ciclesonide)
• Zetonna (ciclesonide)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Perennial Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2014-07-24